EGI
ISEE

EAM Global Investors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

EAM Global Investors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-178,456
Closed -$4.34M – 132
2023
Q1 		$4.34M Buy
178,456
+16,352
+10% +$358K 1.22% 36
2022
Q4 		$3.47M Sell
162,104
-54,102
-25% -$1.15M 0.9% 23
2022
Q3 		$3.88M Buy
+216,206
New +$2.84M 1.03% 15
2022
Q2 		– Sell
-246,521
Closed -$4.15M – 284
2022
Q1 		$4.15M Sell
246,521
-17,692
-7% -$261K 0.77% 30
2021
Q4 		$4.42M Buy
264,213
+14,371
+6% +$236K 0.78% 20
2021
Q3 		$4.06M Buy
+249,842
New +$2.72M 0.96% 13

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

EAM Global Investors's ISEE Position: Q2 2023 in Review

EAM Global Investors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 178,456 shares — an estimated $4.34M sold.

EAM Global Investors first reported a position in ISEE in Q3 2021 and held it in 6 quarters. The position peaked at $4.42M in Q4 2021. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • EAM Global Investors reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • EAM Global Investors sold 178,456 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $4.34M.
  • EAM Global Investors first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • EAM Global Investors's IVERIC bio, Inc. Common Stock position peaked at $4.42M in Q4 2021.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on EAM Global Investors's 13F filing for Q2 2023, filed 11 Aug 2023.